FibroGen, Inc revenue for the last year amounted to 29.62 M USD, the most of which — 29.62 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 147.75 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought FibroGen, Inc 26.11 M USD, and the year before that — 12.96 M USD.